GlassScriptPhysician profile
Richard K Hood
NPI 1083615272
$3,840.36
in general payments reported to CMS, 2019-2025
31 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $390 · 2021: $554 · 2022: $536 · 2023: $699 · 2024: $622 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,883.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,573.38 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $460.48 | 2021-2024 | |
| Nevro Corp. | $418.69 | 2019-2024 | Senza |
| Globus Medical, INC. | $255.03 | 2025 | Senza |
| Allergan, INC. | $185.97 | 2019-2022 | |
| Si-Bone, INC. | $152.66 | 2019-2023 | |
| Medtronic, INC. | $83.44 | 2022-2025 | Inceptiv |
| Boston Scientific Corporation | $81.91 | 2023-2025 | Intracept |
| Scilex Pharmaceuticals INC. | $68.88 | 2019-2020 | |
| Pfizer INC. | $65.97 | 2019-2021 | |
| Pacira Therapeutics, INC. | $43.63 | 2019-2020 | |
| Mml US, INC. | $42.18 | 2025 | Reactiv8 |
| Redhill Biopharma INC. | $39.48 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $39.12 | 2019 | |
| Amgen INC. | $31.20 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $31.05 | 2021 | |
| Spr Therapeutics, INC | $26.35 | 2024 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $23.88 | 2019 | |
| Avanos Medical | $23.67 | 2024 | Standard Rf Disposables |
| Ermi LLC | $20.05 | 2019 | |
| Coastal Medical Technologies LLC | $20.05 | 2023 | |
| Fidia Pharma USA INC. | $18.76 | 2020 | |
| Almatica Pharma LLC | $18.23 | 2022 | |
| Orthofix Medical, INC. | $17.65 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.19 | 2023 | Relistor |
| Kaleo, INC. | $16.53 | 2019 | |
| Medtronic USA, INC. | $14.68 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.52 | 2019 | |
| Smith+Nephew, INC. | $14.04 | 2023 | Pico |
| Lilly USA, LLC | $12.36 | 2019 | |
| Kerecis Limited | $9.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.